Form 4 · Filed Jun 1, 2026, 10:00 PM UTC
ACAD/ACADIA PHARMACEUTICALS INC
Daly James M — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | M | other | 8,107 | — | — | 12,148 |
| May 29, 2026 | M | other | 8,107 | — | — | 0 |
| May 29, 2026 | A | other | 16,004 | — | — | 16,004 |
| May 29, 2026 | A | other | 9,311 | — | — | 9,311 |
Source: SEC EDGAR raw filing ↗ · Accession 0001560782-26-000002